“Low Dose Naltrexone (LDN) is a drug that is credited with helping those with HIV/AIDS, cancer, autoimmune diseases, and central nervous system disorders (including MS) by boosting the immune system. As well as being effective it is cheap, costing less than one pound a day, and could save the NHS vast sums of money. We therefore urge the Govenment to fund a trial of LDN on the NHS so that everyone in the UK can reap the benefits of this drug.”
LDN is not a miracle drug as many seem determined to claim, it is in fact a drug that implements the biotherapy approach to medicine, which is all about artificially stimulating the bodies own defenses and systems in order to restore control over systemic diseases. This control is how most people remain clear of these diseases in normal health. The immune system we have has evolved over billions of years and does many jobs far better than our modern, symptom relief drug culture ever can.
Letter to your MP to support the petition to the House of Commons. Please download and use to write to your MP. Feel free to personalise this letter too.
NEW Video from LDNScience - How LDN Works - LDNscience™ – Communicating all the scientific research and rationale for Low Dose Naltrexone (LDN), Opioid Growth Factor (OGF) and related therapies. LDNscience™ is a project of the MedInsight® Research Institute.at LDNScience.org.
Dr Chris Steele MBE from ITV 'This Morning" supports the LDN petition on YouTube, seen here handing in the petition to number 10 Downing Street with 13028 signatures. The response once again points us at the government sponsored body NIHR Health Technology Assessment programme, a body established to fund and pursue research which cannot find funding commercially. We have asked them for research on use as a front line, first do no harm, and safe therapy, for use with Cancer and autoimmune diseases. As versatile as steroids, but without the bad side effects! Remember, first of all, LDN is safe, and if a rebalanced immune system was a problem to people with autoimmune diseases, then how come all us LDN users are doing so well?
Please sign the EU petition. The EU petition takes this issue to the point about human rights. We feel that a person who requests LDN as a safe option should be able to get it easily. It is often the sick themselves who know what they need. But we also request that they make the research a reality, not just a notion assuming someone will do it eventually.
The application for research at NIHR has been considered and the response now is much more positive and helpful. We have established a definite way forward but there is still no guarantee of success. However, thankyou to NIHR for their help in this matter and their openness.
Sam Blyth, youngest ever to be diagnosed with MS supports the LDNNow campaign. His story can be found on the MSRC website . His mother Sandra explains her frustration about LDN not being offered as a front line, first do no harm, option. LDNNow wishes Sam a great new year and all the support he needs to overcome his MS. It is very much for people like Sam that we need research and licensing of LDN on the NHS as a matter of urgency, and we look forward to a positive response from NIHR when they respond fully on 3rd March 2010, on our request to them for research in their Health Technology Assessment programme.
The petition to number 10 in one year, achieved 13028 signatures demanding that the government funds the trials for Low Dose Naltrexone for the diseases that it treats if that is what is required to make it available on the NHS as a front line, 'first do no harm' treatment option for diseases like CANCER, MS, RHEUMATOID ARTHRITIS, HIV/AIDS and Autoimmune conditions in general and even INFERTILITY requiring IVF! and more besides.
Sam Blyth, youngest ever to be diagnosed with MS supports the LDNNow campaign. His story can be found on the